A carregar...
T-bet promotes potent antitumor activity of CD4(+) CAR T cells
Chimeric antigen receptor (CAR) therapy has shown promise against B cell malignancies in the clinic. However, limited success in patients with solid tumors has prompted the development of new CAR strategies. In this study, a B7H6-specific CAR was combined with different variants of T-bet, a transcri...
Na minha lista:
| Publicado no: | Cancer Gene Ther |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Nature Publishing Group US
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6021366/ https://ncbi.nlm.nih.gov/pubmed/29515240 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41417-018-0012-7 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|